Transpupillary Thermotherapy versus Plaque Radiotherapy for Suspected Choroidal Melanomas

J. William Harbour, Travis A. Meredith, Paul A. Thompson, Mae E. Gordon

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Purpose: To examine the outcomes and complications of transpupillary thermotherapy for treatment of small choroidal melanomas. Design: Retrospective case-matched comparative study and retrospective observational study. Participants: The case-matched study consisted of 36 patients treated with either transpupillary thermotherapy or plaque radiotherapy (18 patients per group). The observational study consisted of 21 patients treated with transpupillary thermotherapy alone (primary transpupillary thermotherapy) and 9 patients treated with transpupillary thermotherapy plus plaque radiotherapy (adjuvant transpupillary thermotherapy). Main Outcome Measures: Visual acuity, local tumor control, and metastasis. Results: The case-matched groups did not differ significantly with respect to age, gender, initial visual acuity, tumor location, or length of follow-up (mean, 33 months for transpupillary thermotherapy vs. 40 months for plaque radiotherapy). There was no significant difference in final visual acuity (P = 0.810) or postoperative visual acuity change (P = 0.919) between the 2 groups. In the observational study, the mean follow-up was 32 months (range, 4-58 months). Indications for primary transpupillary thermotherapy included documented growth (10 patients) and the presence of ≥3 risk factors for growth (11 patients). Retinal complications occurred in 16 patients (76%). The mean posttreatment visual acuity change was minus 2 lines (range, minus 9 to plus 7 lines). Local failure occurred in 6 patients (29%). Local failure was associated with an increased number of transpupillary thermotherapy spots per session (P = 0.023) and decreased tumor pigmentation (P = 0.001). Indications for adjuvant transpupillary thermotherapy included tumor radioresistance (6 patients) and the presence of risk factors for local failure (3 patients). All 9 tumors that received adjuvant transpupillary thermotherapy regressed rapidly, with no local failures. The mean postoperative visual acuity change was -1.9 lines (range, -9 to +5 lines). No patient in either study developed metastasis. Conclusions: The recent interest in transpupillary thermotherapy as primary therapy for choroidal melanoma is based largely on the assumption that transpupillary thermotherapy may provide better visual outcomes than plaque radiotherapy. However, this study found no significant difference in visual outcomes between transpupillary thermotherapy and plaque radiotherapy. Further, the local failure rate with transpupillary thermotherapy was substantially higher than with plaque radiotherapy. The most promising role for transpupillary thermotherapy seems to be as an adjunct to plaque radiotherapy. The appropriate indications for transpupillary thermotherapy in the management of choroidal melanoma need to be re-evaluated.

Original languageEnglish
Pages (from-to)2207-2214
Number of pages8
JournalOphthalmology
Volume110
Issue number11
DOIs
StatePublished - Nov 1 2003
Externally publishedYes

Fingerprint

Induced Hyperthermia
Melanoma
Radiotherapy
Visual Acuity
Observational Studies
Neoplasms
Neoplasm Metastasis
Adjuvant Radiotherapy
Pigmentation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Transpupillary Thermotherapy versus Plaque Radiotherapy for Suspected Choroidal Melanomas. / William Harbour, J.; Meredith, Travis A.; Thompson, Paul A.; Gordon, Mae E.

In: Ophthalmology, Vol. 110, No. 11, 01.11.2003, p. 2207-2214.

Research output: Contribution to journalArticle

William Harbour, J. ; Meredith, Travis A. ; Thompson, Paul A. ; Gordon, Mae E. / Transpupillary Thermotherapy versus Plaque Radiotherapy for Suspected Choroidal Melanomas. In: Ophthalmology. 2003 ; Vol. 110, No. 11. pp. 2207-2214.
@article{12ceceea34834e59a80d149baa78ea02,
title = "Transpupillary Thermotherapy versus Plaque Radiotherapy for Suspected Choroidal Melanomas",
abstract = "Purpose: To examine the outcomes and complications of transpupillary thermotherapy for treatment of small choroidal melanomas. Design: Retrospective case-matched comparative study and retrospective observational study. Participants: The case-matched study consisted of 36 patients treated with either transpupillary thermotherapy or plaque radiotherapy (18 patients per group). The observational study consisted of 21 patients treated with transpupillary thermotherapy alone (primary transpupillary thermotherapy) and 9 patients treated with transpupillary thermotherapy plus plaque radiotherapy (adjuvant transpupillary thermotherapy). Main Outcome Measures: Visual acuity, local tumor control, and metastasis. Results: The case-matched groups did not differ significantly with respect to age, gender, initial visual acuity, tumor location, or length of follow-up (mean, 33 months for transpupillary thermotherapy vs. 40 months for plaque radiotherapy). There was no significant difference in final visual acuity (P = 0.810) or postoperative visual acuity change (P = 0.919) between the 2 groups. In the observational study, the mean follow-up was 32 months (range, 4-58 months). Indications for primary transpupillary thermotherapy included documented growth (10 patients) and the presence of ≥3 risk factors for growth (11 patients). Retinal complications occurred in 16 patients (76{\%}). The mean posttreatment visual acuity change was minus 2 lines (range, minus 9 to plus 7 lines). Local failure occurred in 6 patients (29{\%}). Local failure was associated with an increased number of transpupillary thermotherapy spots per session (P = 0.023) and decreased tumor pigmentation (P = 0.001). Indications for adjuvant transpupillary thermotherapy included tumor radioresistance (6 patients) and the presence of risk factors for local failure (3 patients). All 9 tumors that received adjuvant transpupillary thermotherapy regressed rapidly, with no local failures. The mean postoperative visual acuity change was -1.9 lines (range, -9 to +5 lines). No patient in either study developed metastasis. Conclusions: The recent interest in transpupillary thermotherapy as primary therapy for choroidal melanoma is based largely on the assumption that transpupillary thermotherapy may provide better visual outcomes than plaque radiotherapy. However, this study found no significant difference in visual outcomes between transpupillary thermotherapy and plaque radiotherapy. Further, the local failure rate with transpupillary thermotherapy was substantially higher than with plaque radiotherapy. The most promising role for transpupillary thermotherapy seems to be as an adjunct to plaque radiotherapy. The appropriate indications for transpupillary thermotherapy in the management of choroidal melanoma need to be re-evaluated.",
author = "{William Harbour}, J. and Meredith, {Travis A.} and Thompson, {Paul A.} and Gordon, {Mae E.}",
year = "2003",
month = "11",
day = "1",
doi = "10.1016/S0161-6420(03)00858-3",
language = "English",
volume = "110",
pages = "2207--2214",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Transpupillary Thermotherapy versus Plaque Radiotherapy for Suspected Choroidal Melanomas

AU - William Harbour, J.

AU - Meredith, Travis A.

AU - Thompson, Paul A.

AU - Gordon, Mae E.

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Purpose: To examine the outcomes and complications of transpupillary thermotherapy for treatment of small choroidal melanomas. Design: Retrospective case-matched comparative study and retrospective observational study. Participants: The case-matched study consisted of 36 patients treated with either transpupillary thermotherapy or plaque radiotherapy (18 patients per group). The observational study consisted of 21 patients treated with transpupillary thermotherapy alone (primary transpupillary thermotherapy) and 9 patients treated with transpupillary thermotherapy plus plaque radiotherapy (adjuvant transpupillary thermotherapy). Main Outcome Measures: Visual acuity, local tumor control, and metastasis. Results: The case-matched groups did not differ significantly with respect to age, gender, initial visual acuity, tumor location, or length of follow-up (mean, 33 months for transpupillary thermotherapy vs. 40 months for plaque radiotherapy). There was no significant difference in final visual acuity (P = 0.810) or postoperative visual acuity change (P = 0.919) between the 2 groups. In the observational study, the mean follow-up was 32 months (range, 4-58 months). Indications for primary transpupillary thermotherapy included documented growth (10 patients) and the presence of ≥3 risk factors for growth (11 patients). Retinal complications occurred in 16 patients (76%). The mean posttreatment visual acuity change was minus 2 lines (range, minus 9 to plus 7 lines). Local failure occurred in 6 patients (29%). Local failure was associated with an increased number of transpupillary thermotherapy spots per session (P = 0.023) and decreased tumor pigmentation (P = 0.001). Indications for adjuvant transpupillary thermotherapy included tumor radioresistance (6 patients) and the presence of risk factors for local failure (3 patients). All 9 tumors that received adjuvant transpupillary thermotherapy regressed rapidly, with no local failures. The mean postoperative visual acuity change was -1.9 lines (range, -9 to +5 lines). No patient in either study developed metastasis. Conclusions: The recent interest in transpupillary thermotherapy as primary therapy for choroidal melanoma is based largely on the assumption that transpupillary thermotherapy may provide better visual outcomes than plaque radiotherapy. However, this study found no significant difference in visual outcomes between transpupillary thermotherapy and plaque radiotherapy. Further, the local failure rate with transpupillary thermotherapy was substantially higher than with plaque radiotherapy. The most promising role for transpupillary thermotherapy seems to be as an adjunct to plaque radiotherapy. The appropriate indications for transpupillary thermotherapy in the management of choroidal melanoma need to be re-evaluated.

AB - Purpose: To examine the outcomes and complications of transpupillary thermotherapy for treatment of small choroidal melanomas. Design: Retrospective case-matched comparative study and retrospective observational study. Participants: The case-matched study consisted of 36 patients treated with either transpupillary thermotherapy or plaque radiotherapy (18 patients per group). The observational study consisted of 21 patients treated with transpupillary thermotherapy alone (primary transpupillary thermotherapy) and 9 patients treated with transpupillary thermotherapy plus plaque radiotherapy (adjuvant transpupillary thermotherapy). Main Outcome Measures: Visual acuity, local tumor control, and metastasis. Results: The case-matched groups did not differ significantly with respect to age, gender, initial visual acuity, tumor location, or length of follow-up (mean, 33 months for transpupillary thermotherapy vs. 40 months for plaque radiotherapy). There was no significant difference in final visual acuity (P = 0.810) or postoperative visual acuity change (P = 0.919) between the 2 groups. In the observational study, the mean follow-up was 32 months (range, 4-58 months). Indications for primary transpupillary thermotherapy included documented growth (10 patients) and the presence of ≥3 risk factors for growth (11 patients). Retinal complications occurred in 16 patients (76%). The mean posttreatment visual acuity change was minus 2 lines (range, minus 9 to plus 7 lines). Local failure occurred in 6 patients (29%). Local failure was associated with an increased number of transpupillary thermotherapy spots per session (P = 0.023) and decreased tumor pigmentation (P = 0.001). Indications for adjuvant transpupillary thermotherapy included tumor radioresistance (6 patients) and the presence of risk factors for local failure (3 patients). All 9 tumors that received adjuvant transpupillary thermotherapy regressed rapidly, with no local failures. The mean postoperative visual acuity change was -1.9 lines (range, -9 to +5 lines). No patient in either study developed metastasis. Conclusions: The recent interest in transpupillary thermotherapy as primary therapy for choroidal melanoma is based largely on the assumption that transpupillary thermotherapy may provide better visual outcomes than plaque radiotherapy. However, this study found no significant difference in visual outcomes between transpupillary thermotherapy and plaque radiotherapy. Further, the local failure rate with transpupillary thermotherapy was substantially higher than with plaque radiotherapy. The most promising role for transpupillary thermotherapy seems to be as an adjunct to plaque radiotherapy. The appropriate indications for transpupillary thermotherapy in the management of choroidal melanoma need to be re-evaluated.

UR - http://www.scopus.com/inward/record.url?scp=0242349272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242349272&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(03)00858-3

DO - 10.1016/S0161-6420(03)00858-3

M3 - Article

C2 - 14597531

AN - SCOPUS:0242349272

VL - 110

SP - 2207

EP - 2214

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 11

ER -